Company Description
ANGN (NASDAQ: angn) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $30.1M.
angn stock has declined 38.6% over the past year.
This page provides a comprehensive overview of angn stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ANGN (angn) stock. Over the past 12 months, the stock has lost 38.6%. At a market capitalization of $30.1M, angn is classified as a micro-cap stock.
Latest News
ANGN has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include stock split, acquisition, earnings, clinical trial. View all angn news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
angn Company Profile & Sector Positioning
ANGN (angn) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.